What is Roth Capital’s Estimate for SNYR FY2024 Earnings?

Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) – Investment analysts at Roth Capital issued their FY2024 earnings estimates for Synergy CHC Corp. (Uplisting) in a research note issued on Tuesday, January 21st. Roth Capital analyst S. Mcgowan anticipates that the company will post earnings per share of $0.36 for the year. Roth Capital has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for Synergy CHC Corp. (Uplisting)’s Q4 2024 earnings at $0.10 EPS, Q1 2025 earnings at $0.07 EPS, Q2 2025 earnings at $0.13 EPS, Q3 2025 earnings at $0.15 EPS, Q4 2025 earnings at $0.24 EPS, FY2025 earnings at $0.59 EPS, Q1 2026 earnings at $0.14 EPS, Q2 2026 earnings at $0.20 EPS, Q3 2026 earnings at $0.21 EPS, Q4 2026 earnings at $0.32 EPS and FY2026 earnings at $0.87 EPS.

Separately, Roth Mkm started coverage on Synergy CHC Corp. (Uplisting) in a research note on Tuesday. They set a “buy” rating and a $10.00 price objective on the stock.

Synergy CHC Corp. (Uplisting) Stock Up 1.2 %

Shares of NASDAQ SNYR opened at $4.11 on Thursday. The company’s 50 day moving average is $5.11. Synergy CHC Corp. has a 52 week low of $0.12 and a 52 week high of $10.00.

Synergy CHC Corp. (Uplisting) (NASDAQ:SNYR) last announced its quarterly earnings data on Friday, December 6th. The company reported $0.10 earnings per share for the quarter.

Synergy CHC Corp. (Uplisting) Company Profile

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.